Free CEUs for Advanced Nurse Practitioners
The CME & Pharmacology Hours You Need Today for ANP License Renewal
|
WELCOME! We are proud to sponsor this educational initiative, dedicated to providing free CME & CEUs required by many state boards for NP, Advanced Practice Nurse license renewal. Check back often for new free Nurse Practitioner CME courses offering free CEUs that are posted frequently. Through extensive content review, our staff approves NP CEU courses that are timely and approved by the AANP.
ALL CEU, CME & contact hour offerings are FREE! |
|
Select a course by clicking the title. Courses or fees may have changed on provider’s websites since their posting here. Always check the provider’s website for accreditation information, terms and conditions of courses offered. Courses listed here are not the property of FreeCME4Me, nor do we offer any courses & are not responsible for the those posted on this site
|
To check ANP CME requirements by STATE CLICK HERE!
|
|
Antiretroviral Therapy: Optimizing Treatment for HIV-infected Patients- Review considerations involved in choosing an antiretroviral regimen for initial therapy, Evaluate options for switching therapy when a patient is experiencing side effects or drug-drug interactions, and Review best practices for monitoring HIV-infected patients on antiretroviral therapy. 2.0 Free Contact Hours which includes 2.0 Hours of Pharmacology
Preventive Health Care- Screening is an effective method for detecting and preventing acute and chronic diseases. In the United States healthcare tends to be provided after someone has become unwell and medical attention is sought. Poor health habits play a large part in the pathogenesis and progression of many common, chronic diseases. Conversely, healthy habits are very effective at preventing many diseases. The common causes of chronic disease and prevention are discussed with a primary focus on the role of health professionals to provide preventive healthcare and to educate patients to recognize risk factors and to avoid a chronic disease. 4.0 Free Contact Hours which includes 0.5 Hours of Pharmacology |
& be notified when new FREE CME has posted!
|
|
Featured Free CME of the Month NEW! INDIVIDUALIZING HEART FAILURE TREATMENT- Know the risk factors for heart failure and the role of biomarkers in diagnosis and treatment. Recognize the importance of heart rate in cardiovascular risk of heart failure. Utilize the most recent clinical evidence to inform decisions for the management of heart failure. Identify approaches to facilitate early recognition and optimization of heart failure management. 1.0 Free Contact Hours which includes 0.25 Hours of Pharmacology (+MD)
NEW! Best Practice in Care for the Menopausal Patient: 14 Years after the Women's Health Initiative- Identify key conclusions of the preliminary and subsequent findings of the WHI as reported by the Principal Investigators of the study. Describe reporting components from the WHI conclusions that factored into misinterpretations into the analysis of risks and benefits associated with use of hormone therapy in postmenopausal women. Discuss the short- and long-term consequences to menopausal women, especially in younger women who are likely to be more symptomatic, if clinicians do not explore the severity of menopausal transition in their aging female patients. Discuss evidence-based hormone therapy guidelines issued from renowned health organizations for treatment and management of various symptoms and comorbidities associated with menopausal transition. Apply risk benefits to the clinical case studies presented to determine best practice decisions in recommending pharmacological vs non-pharmacological therapeutic options for management of menopausal transition. 1.25 Free Contact Hours which includes 1.25 Hours of Pharmacology (+MD) Emerging Insulin Agents and the Pivotal Role of Nurse Practitioners and Physician Assistants in Improving Diabetes Outcomes- Apply knowledge of the phamacokinetic profiles of insulin formulations to develop an individualized insulin regimen from diagnosis to ongoing management, ensuring achievement of HbA1c goals and reducing the risk of complications. Evaluate the place of new and emerging insulin formulations in the treatment armamentarium for diabetes. Incorporate e¬ffective strategies for providing patient education and psychological support for patients with diabetes who are initiating or continuing insulin therapy 1.0 Free Contact Hours which includes 0.25 Hours of Pharmacology (+MD)
|
Stroke Prevention in Atrial Fibrillation: Current Evidence for Tailoring Antithrombotic Therapy- Apply evidence-based scoring assessments to properly risk stratify patients with atrial fibrillation, considering stroke and bleeding risks.Discuss key differences in the pharmacologic profiles of the new oral anticoagulants that may impact selection of a specific agent for an individual patient with atrial fibrillation. Select the correct dosage for oral anticoagulant therapy for patients with atrial fibrillation and renal impairment. Develop individualized guideline-based antithrombotic treatment regimens for stroke prevention in patients with atrial fibrillation. 1.0 Free Contact Hours/0.8 Hours of Pharmacology
Addressing the Contraception Needs of Adolescents and Young Adults- Describe the rate of unintended pregnancy in the United States. Identify evidence-based guidelines about contraceptive eligibility criteria. Describe contraception counseling utilizing a shared decision making framework. Counsel patients about a range of contraception options including method initiation and management of common side effects. Discuss the safety and efficacy of long-acting reversible contraceptives (LARC) including IUDs and implants. List clinician and patient contraception related resources. Consider systems practices which can affect contraceptive initiation and continuation. 1.0 Free Contact Hours which includes 0.5 Hours of pharmacology (+MD)
Improving the Management of Depression in Primary Care: Insights into Diagnosis and Treatment- Summarize guideline changes in the new Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, that impact the diagnosis and assessment of MDD. Assess the severity and risks of depression at the time of diagnosis. Summarize current evidence for efficacy and safety of new therapies recently approved for the treatment of depression. Develop customized treatment regimens for adults with depression, considering medication efficacy and safety, drug interactions, dosing options, and patient comorbidities. Explain the benefits of using rating scales to assess patient response to depression treatment and medication side effects.1.0 Free Contact Hours which includes 0.5 Free Hours of Pharmacology
Meeting Quality Measures and Improving Outcomes in Heart Failure Patients With Comorbidities: Where Do New Therapies Fit? Describe the interrelationships of pathophysiology in heart failure (HF) and metabolic syndrome. Assess how current HF therapies can be used synergistically in the treatment of patients with comorbid metabolic syndrome. Evaluate the efficacy and safety of newly approved therapies for treating patients with HF and comorbid metabolic syndrome. 1.0 Free Contact Hours which includes 1.0 Hours of Pharmacology (+MD, RPh, RD)
Menopausal Symptoms: Comparative Effectiveness of Therapies- Discuss the comparative effectiveness of different treatments for reducing menopausal symptoms and improving quality of life. Discuss the effects of menopausal hormone therapy preparations on coronary heart disease, stroke, or venous thromboembolism; gallbladder disease; osteoporotic fractures; or endometrial, breast, colorectal, and ovarian cancer. Discuss the effects of nonhormone therapy preparations on coronary heart disease, stroke, or venous thromboembolism; gallbladder disease; osteoporotic fractures; and endometrial, breast, colorectal, and ovarian cancer. Identify factors that affect the applicability of the results of the review. 1.0 Free Contact Hours (+MD, RPh, RN ,CCM)
Addressing the Contraception Needs of Adolescents and Young Adults- Describe the rate of unintended pregnancy in the United States. Identify evidence-based guidelines about contraceptive eligibility criteria. Describe contraception counseling utilizing a shared decision making framework. Counsel patients about a range of contraception options including method initiation and management of common side effects. Discuss the safety and efficacy of long-acting reversible contraceptives (LARC) including IUDs and implants. List clinician and patient contraception related resources. Consider systems practices which can affect contraceptive initiation and continuation. 1.0 Free Contact Hours which includes 0.5 Hours of pharmacology (+MD)
Improving the Management of Depression in Primary Care: Insights into Diagnosis and Treatment- Summarize guideline changes in the new Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, that impact the diagnosis and assessment of MDD. Assess the severity and risks of depression at the time of diagnosis. Summarize current evidence for efficacy and safety of new therapies recently approved for the treatment of depression. Develop customized treatment regimens for adults with depression, considering medication efficacy and safety, drug interactions, dosing options, and patient comorbidities. Explain the benefits of using rating scales to assess patient response to depression treatment and medication side effects.1.0 Free Contact Hours which includes 0.5 Free Hours of Pharmacology
Meeting Quality Measures and Improving Outcomes in Heart Failure Patients With Comorbidities: Where Do New Therapies Fit? Describe the interrelationships of pathophysiology in heart failure (HF) and metabolic syndrome. Assess how current HF therapies can be used synergistically in the treatment of patients with comorbid metabolic syndrome. Evaluate the efficacy and safety of newly approved therapies for treating patients with HF and comorbid metabolic syndrome. 1.0 Free Contact Hours which includes 1.0 Hours of Pharmacology (+MD, RPh, RD)
Menopausal Symptoms: Comparative Effectiveness of Therapies- Discuss the comparative effectiveness of different treatments for reducing menopausal symptoms and improving quality of life. Discuss the effects of menopausal hormone therapy preparations on coronary heart disease, stroke, or venous thromboembolism; gallbladder disease; osteoporotic fractures; or endometrial, breast, colorectal, and ovarian cancer. Discuss the effects of nonhormone therapy preparations on coronary heart disease, stroke, or venous thromboembolism; gallbladder disease; osteoporotic fractures; and endometrial, breast, colorectal, and ovarian cancer. Identify factors that affect the applicability of the results of the review. 1.0 Free Contact Hours (+MD, RPh, RN ,CCM)
WRITING STRONG ABSTRACTS FOR SCIENTIFIC CONFERENCES–Describe the steps in writing an abstract for presentation at a scientific conference. Identify three components that make an abstract strong. Use the information presented to develop a strong draft of an abstract to submit for consideration for presentation at a meeting. 1.0 Free Contact Hours
Optimal Strategies to Reduce Cardioembolic Risk in the Patient with Nonvalvular Atrial Fibrillation: A Patient Centered Approach - Identify the factor(s) in the coagulation cascade on which warfarin, dabigatran, rivaroxaban and apixaban exert their respective anticoagulant effects . Identify sources for evidence-based guidelines for antithrombotic therapy in the reduction of cardioembolic risk in the patient with non-valvular atrial fibrillation. Define the impact of renal function, clinical history, and patient age on the choice of anticoagulant agent. Describe the role of effective clinician/patient communication in the safe management of oral anticoagulation. Outline an efficient method of incorporating shared decision making when developing a treatment plan for the patient with NVAF. 2.25 Free Contact Hours which includes 1.0 Hours of Pharmacology
Asthma Management and Tips for Clinical Documentation- Understand how to classify asthma severity and control. Evaluate the stepwise approach in asthma management. Review optimal pharmacotherapy options in the provision of quality asthma care. Enhance clinical documentation skills for appropriate coding and reimbursement. 1.25 Free Contact Hours
Head Lice: Update on Diagnosis and Treatment- Discuss the etiology and biology of head lice infestationIdentify signs and symptoms of head lice infestation and distinguish between active infestation and other material in hair. Evaluate the effectiveness and risks of various prescription and over-the-counter lice treatment options, particularly newer agents. Counsel parents and patients on proper implementation of various treatments for head lice. 1.0 Free Contact Hours which includes 0.5 Hours of Pharmacology (+MD, RN)
Key Strategies to Keep Heart Failure Patients Out of the Hospital– Evaluate the risk factors and clinical interventions for heart failure. Identify the importance of early follow-up care by PCPs in keeping heart failure patients from being readmitted. Apply new initiatives that PCPs can participate in to help reduce hospital readmissions and improve patient quality of life. 1.0 Free Contact Hours/0.5 Hours of Pharmacology (+MD)
Insurance Billing & Coding- List the steps necessary to keep up to date on latest regarding billing for obesity medicine. Explain why preventive billing and coding did not work for us. Describe how sick billing coding works for us. 0.75 Free Contact Hours (+MD, PA, RD)
Optimal Strategies to Reduce Cardioembolic Risk in the Patient with Nonvalvular Atrial Fibrillation: A Patient Centered Approach - Identify the factor(s) in the coagulation cascade on which warfarin, dabigatran, rivaroxaban and apixaban exert their respective anticoagulant effects . Identify sources for evidence-based guidelines for antithrombotic therapy in the reduction of cardioembolic risk in the patient with non-valvular atrial fibrillation. Define the impact of renal function, clinical history, and patient age on the choice of anticoagulant agent. Describe the role of effective clinician/patient communication in the safe management of oral anticoagulation. Outline an efficient method of incorporating shared decision making when developing a treatment plan for the patient with NVAF. 2.25 Free Contact Hours which includes 1.0 Hours of Pharmacology
Asthma Management and Tips for Clinical Documentation- Understand how to classify asthma severity and control. Evaluate the stepwise approach in asthma management. Review optimal pharmacotherapy options in the provision of quality asthma care. Enhance clinical documentation skills for appropriate coding and reimbursement. 1.25 Free Contact Hours
Head Lice: Update on Diagnosis and Treatment- Discuss the etiology and biology of head lice infestationIdentify signs and symptoms of head lice infestation and distinguish between active infestation and other material in hair. Evaluate the effectiveness and risks of various prescription and over-the-counter lice treatment options, particularly newer agents. Counsel parents and patients on proper implementation of various treatments for head lice. 1.0 Free Contact Hours which includes 0.5 Hours of Pharmacology (+MD, RN)
Key Strategies to Keep Heart Failure Patients Out of the Hospital– Evaluate the risk factors and clinical interventions for heart failure. Identify the importance of early follow-up care by PCPs in keeping heart failure patients from being readmitted. Apply new initiatives that PCPs can participate in to help reduce hospital readmissions and improve patient quality of life. 1.0 Free Contact Hours/0.5 Hours of Pharmacology (+MD)
Insurance Billing & Coding- List the steps necessary to keep up to date on latest regarding billing for obesity medicine. Explain why preventive billing and coding did not work for us. Describe how sick billing coding works for us. 0.75 Free Contact Hours (+MD, PA, RD)
|
|
Evidence-Based Nutrition Management of Preterm Infants- Determine adequate protein requirements for preterm infants. Apply necrotizing enterocolitis (NEC) preventative strategies in the neonatal intensive care unit. Adjoin current controversies in NEC with new treatment modalities. 1.5 Free Contact Hours (+RN, MD, RD, DTR)
Treating to Target Patients with Gout and Chronic Kidney Disease- Execute strategies to enhance an understanding of the association among hyperuricemia, gout, and CKD. Utilize educational resources in shared decision-making discussions with patients to promote medication adherence and optimize outcomes. Implement strategies to achieve optimal clinical and economic outcomes in patients with hyperuricemia or gout and CKD. 1.5 Free Contact Hours which includes 1.5 Hours of Pharmacology (+MD, PA, RPh) |
Intrapartum Sterile Speculum Examination Training for Registered Nurses– Indications for sterile speculum exam (SSE). Pertinent anatomy related to proper SSE of the vulva and perineum. Necessary equipment and specimen collection materials for SSE. Mechanics of the speculum and proper SSE insertion and removal techniques. Important behavioral aspects of nurse-patient interaction during SSE. 1.0 Free CEUs
Emerging Treatment Options for Familial Hypercholesterolemia- Review the underlying genetic mutations and the role of genetic screening for heterozygous familial hypercholesterolemia (HeFH) and homozygous familial hypercholesterolemia (HoFH) as it relates to diagnosis and treatment of familial hypercholesterolemia and in response to statins, ezetimibe and proprotein convertase subtilisin kexin 9 (PCSK9) monoclonal antibody treatment. Discuss the emerging evidence on genetic mutations and their potential therapeutic significance in the development of novel low-density lipoprotein cholesterol (LDL-C) targets. Identify the relationship of LDL-C reduction and cardiovascular disease (CVD) risk reduction including the risk in HeFH and HoFH. Discuss the clinical presentation and implications of HeFH and the use of optimal LDL-C target goals for these patients based on current consensus recommendations. 1.0 Free Contact Hours which includes 0.75 Free Hours of Pharmacology (+MD,PA,RN)
Stroke Prevention in Patients with Atrial Fibrillation- Discuss the epidemiology, pathophysiology, and risk factors for stroke in atrial fibrillation as they relate to prevention.Use validated risk assessment tools to assess and stratify patients with atrial fibrillation for the risk of stroke in order to individualize decisions regarding the appropriateness of stroke prophylaxis. Describe approved anticoagulants, including their mechanism of action, safety, efficacy, indications, and contraindications. Use validated tools to assess bleeding risk in patients treated with anticoagulants. Implement appropriate primary and secondary pharmacologic and nonpharmacologic interventions for stroke prevention tailored to risk stratification and patient characteristics, with knowledge of clinical guidelines, recommendations, and considerations of special populations. 1.25 Free Contact Hours which includes 1.25 Hours of Pharmacology (Register for course)
Code Stroke: New Approaches to Assess and Treat Acute Ischemic Stroke– Utilize recommended stroke-evaluation time benchmarks to stabilize patients within 60 minutes of arrival in the emergency department, including initial evaluation, assessment, imaging, and laboratory studies. Outline current treatments for acute ischemic stroke, including IV thrombolytic therapy with tissue-type plasminogen activator and endovascular therapies, such as intra-arterial thrombolytic therapy and the use of clot-retrieval devices. Interpret stroke trial data that have shown the benefit of using neuroimaging to select patients who are most likely to benefit from thrombolytic therapy and the potential benefits of extending the window for thrombolytic therapy beyond the guideline of 3 hours with tPA and newer agents. Utilize tools to predict patients’ clinical response and risk of hemorrhagic complications following IV thrombolytic therapy. Interpret the latest clinical trial data (examples: ESCAPE, EXTEND-IA, REVASCAT, SWIFT PRIME, MR CLEAN) evaluating endovascular therapy in the management of acute ischemic stroke and how this data applies to current practice. 1.4 Free Contact Hrs which includes 1.4 Hours of Pharmacology (+MD)
Heart Failure Management: A 2016 Update- List two new drug classes approved in 2015 for the treatment of heart failure. List two specific goals for patient education regarding risk and benefit for these new therapies. Identify the indications for the use of ivabradine. Identify the indications for the use of the combination agent sacubitril/valsartan in the patient with heart failure. 1.0 Free Contact Hours which includes 1.0 Hours of Pharmacology
Emerging Treatment Options for Familial Hypercholesterolemia- Review the underlying genetic mutations and the role of genetic screening for heterozygous familial hypercholesterolemia (HeFH) and homozygous familial hypercholesterolemia (HoFH) as it relates to diagnosis and treatment of familial hypercholesterolemia and in response to statins, ezetimibe and proprotein convertase subtilisin kexin 9 (PCSK9) monoclonal antibody treatment. Discuss the emerging evidence on genetic mutations and their potential therapeutic significance in the development of novel low-density lipoprotein cholesterol (LDL-C) targets. Identify the relationship of LDL-C reduction and cardiovascular disease (CVD) risk reduction including the risk in HeFH and HoFH. Discuss the clinical presentation and implications of HeFH and the use of optimal LDL-C target goals for these patients based on current consensus recommendations. 1.0 Free Contact Hours which includes 0.75 Free Hours of Pharmacology (+MD,PA,RN)
Stroke Prevention in Patients with Atrial Fibrillation- Discuss the epidemiology, pathophysiology, and risk factors for stroke in atrial fibrillation as they relate to prevention.Use validated risk assessment tools to assess and stratify patients with atrial fibrillation for the risk of stroke in order to individualize decisions regarding the appropriateness of stroke prophylaxis. Describe approved anticoagulants, including their mechanism of action, safety, efficacy, indications, and contraindications. Use validated tools to assess bleeding risk in patients treated with anticoagulants. Implement appropriate primary and secondary pharmacologic and nonpharmacologic interventions for stroke prevention tailored to risk stratification and patient characteristics, with knowledge of clinical guidelines, recommendations, and considerations of special populations. 1.25 Free Contact Hours which includes 1.25 Hours of Pharmacology (Register for course)
Code Stroke: New Approaches to Assess and Treat Acute Ischemic Stroke– Utilize recommended stroke-evaluation time benchmarks to stabilize patients within 60 minutes of arrival in the emergency department, including initial evaluation, assessment, imaging, and laboratory studies. Outline current treatments for acute ischemic stroke, including IV thrombolytic therapy with tissue-type plasminogen activator and endovascular therapies, such as intra-arterial thrombolytic therapy and the use of clot-retrieval devices. Interpret stroke trial data that have shown the benefit of using neuroimaging to select patients who are most likely to benefit from thrombolytic therapy and the potential benefits of extending the window for thrombolytic therapy beyond the guideline of 3 hours with tPA and newer agents. Utilize tools to predict patients’ clinical response and risk of hemorrhagic complications following IV thrombolytic therapy. Interpret the latest clinical trial data (examples: ESCAPE, EXTEND-IA, REVASCAT, SWIFT PRIME, MR CLEAN) evaluating endovascular therapy in the management of acute ischemic stroke and how this data applies to current practice. 1.4 Free Contact Hrs which includes 1.4 Hours of Pharmacology (+MD)
Heart Failure Management: A 2016 Update- List two new drug classes approved in 2015 for the treatment of heart failure. List two specific goals for patient education regarding risk and benefit for these new therapies. Identify the indications for the use of ivabradine. Identify the indications for the use of the combination agent sacubitril/valsartan in the patient with heart failure. 1.0 Free Contact Hours which includes 1.0 Hours of Pharmacology
|
|
|
|